Profile | GDS2987 / GI_40807468-S |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | 66.2 | 73 |
GSM215244 | HMVEC_vehicle_rep2 | 120 | 78 |
GSM215253 | HMVEC_vehicle_rep3 | 71.4 | 74 |
GSM215254 | HMVEC_atorvastatin_rep1 | 23.9 | 52 |
GSM215282 | HMVEC_atorvastatin_rep3 | 23.6 | 48 |
GSM215344 | HMVEC_atorvastatin_rep2 | 12 | 29 |
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | 116 | 77 |
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | 107.1 | 76 |
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | 67.6 | 69 |
GSM215294 | HMVEC_SLx2119_rep1 | 36.1 | 67 |
GSM215295 | HMVEC_SLx2119_rep2 | 38.7 | 59 |
GSM215296 | HMVEC_SLx2119_rep3 | 68.4 | 69 |
GSM215297 | PASMC_vehicle_rep1 | 37 | 49 |
GSM215298 | PASMC_vehicle_rep2 | ||
GSM215310 | PASMC_vehicle_rep3 | 27.1 | 40 |
GSM215311 | PASMC_atorvastatin_rep1 | 6.1 | 11 |
GSM215312 | PASMC_atorvastatin_rep2 | ||
GSM215313 | PASMC_atorvastatin_rep3 | 18 | 27 |
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | ||
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | 11.3 | 22 |
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | 3.5 | 6 |
GSM215327 | PASMC_SLx2119_rep1 | 22.4 | 37 |
GSM215328 | PASMC_SLx2119_rep2 | 1.4 | 3 |
GSM215329 | PASMC_SLx2119_rep3 | ||
GSM215330 | Fibroblasts_vehicle_rep1 | 214.6 | 82 |
GSM215331 | Fibroblasts_vehicle_rep2 | 216.4 | 82 |
GSM215332 | Fibroblasts_vehicle_rep3 | 229.7 | 83 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | 221.4 | 83 |
GSM215334 | Fibroblasts_atorvastatin_rep2 | 229.7 | 82 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | 226.4 | 82 |
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 185.5 | 81 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | 205.1 | 82 |
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | 219.5 | 82 |
GSM215339 | Fibroblasts_SLx2119_rep1 | 271.3 | 84 |
GSM215340 | Fibroblasts_SLx2119_rep2 | 244.2 | 83 |
GSM215341 | Fibroblasts_SLx2119_rep3 | 234.7 | 83 |